Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Sep-24 4:09 PM View:  | Morales Mallory Chief Accounting Officer | Immuneering Corp (IMRX) | 15-Sep-24 | Grant | 4,458 | $1.62 | $7,237.56 | 54% 8.28K to 12.74K | |
| 03-Apr-24 5:37 PM View: | Cormorant Asset Management,... 10% Owner | Immuneering Corp (IMRX) | 01-Apr-24 | Sale | 400,000 | $2.90 | $1,160,180.00 | (2%) 26.36M to 25.96M | |
| 25-Mar-24 9:10 AM View: | Brakewood Harold Eugene Chief Business Officer | Immuneering Corp (IMRX) | 22-Mar-24 | Private Purchase | 3,900 | $2.57 | $10,015.20 | 100% 0 to 3.9K | |
| 25-Mar-24 4:03 PM View: | Schall Thomas J. Director | Immuneering Corp (IMRX) | 22-Mar-24 | Private Purchase | 2,900 | $2.55 | $7,384.85 | 100% 0 to 2.9K | |
| 25-Mar-24 9:13 AM View: | Feinberg Peter Director | Immuneering Corp (IMRX) | 22-Mar-24 | Private Purchase | 25,000 | $2.55 | $63,712.50 | 2% 1.07M to 1.1M | |
| 25-Mar-24 9:04 AM View: | Morales Mallory Chief Accounting Officer | Immuneering Corp (IMRX) | 22-Mar-24 | Purchase | 393 | $2.55 | $1,000.38 | 5% 7.88K to 8.28K | |
| 25-Mar-24 9:04 AM View: | Morales Mallory Chief Accounting Officer | Immuneering Corp (IMRX) | 21-Mar-24 | Purchase | 1,107 | $2.72 | $3,008.72 | 16% 6.78K to 7.88K | |
| 21-Mar-24 9:06 AM View: | Hall Brett Matthew Chief Scientific Officer | Immuneering Corp (IMRX) | 20-Mar-24 | Purchase | 7,000 | $2.86 | $20,020.00 | 2% 338.9K to 345.9K | |
| 21-Mar-24 9:11 AM View: | Neufeld Leah R Chief People Officer | Immuneering Corp (IMRX) | 20-Mar-24 | Purchase | 3,818 | $2.88 | $10,993.20 | 61% 6.21K to 10.03K | |
| 19-Mar-24 6:59 PM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 19-Mar-24 | Private Purchase | 20,000 | $2.77 | $55,326.00 | < 1% 3.16M to 3.18M | |
| 19-Mar-24 7:04 PM View: | Feinberg Peter Director | Immuneering Corp (IMRX) | 19-Mar-24 | Purchase | 25,000 | $2.56 | $64,000.00 | 2% 1.05M to 1.07M | |
| 19-Mar-24 7:10 PM View: | Berman Ann E Director | Immuneering Corp (IMRX) | 18-Mar-24 | Private Purchase | 57,965 | $2.13 | $123,436.00 | 610% 9.5K to 67.47K | |
| 19-Mar-24 7:04 PM View: | Feinberg Peter Director | Immuneering Corp (IMRX) | 18-Mar-24 | Private Purchase | 50,000 | $2.38 | $119,058.00 | 5% 996.06K to 1.05M | |
| 21-Mar-24 9:06 AM View: | Hall Brett Matthew Chief Scientific Officer | Immuneering Corp (IMRX) | 15-Mar-24 | Grant | 6,211 | $1.62 | $10,061.80 | 2% 332.69K to 338.9K | |
| 21-Mar-24 9:11 AM View: | Neufeld Leah R Chief People Officer | Immuneering Corp (IMRX) | 15-Mar-24 | Grant | 6,211 | $1.62 | $10,061.80 | 100% 0 to 6.21K | |
| 19-Mar-24 7:14 PM View: | Bookman Michael CHIEF LEGAL OFFICER, SECRETARY | Immuneering Corp (IMRX) | 15-Mar-24 | Grant | 1,448 | $1.62 | $2,345.76 | 60% 2.4K to 3.85K | |
| 18-Mar-24 5:59 PM View: | Cormorant Asset Management,... 10% Owner | Immuneering Corp (IMRX) | 15-Mar-24 | Sale | 400,000 | $2.14 | $856,400.00 | (2%) 18.72M to 18.32M | |
| 25-Mar-24 9:04 AM View: | Morales Mallory Chief Accounting Officer | Immuneering Corp (IMRX) | 15-Mar-24 | Grant | 4,344 | $1.62 | $7,037.28 | 178% 2.43K to 6.78K | |
| 18-Mar-24 5:59 PM View: | Cormorant Asset Management,... 10% Owner | Immuneering Corp (IMRX) | 14-Mar-24 | Sale | 509,091 | $3.72 | $1,892,600.00 | (3%) 19.23M to 18.72M | |
| 27-Dec-22 8:14 AM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 22-Dec-22 | Option Exercise | 2,500 | $3.01 | $7,525.00 | < 1% 3.15M to 3.16M | |
| 27-May-22 4:09 PM View: | Hall Brett Matthew Chief Scientific Officer | Immuneering Corp (IMRX) | 25-May-22 | Private Purchase | 2,551 | $3.92 | $9,999.92 | < 1% 330.13K to 332.69K | |
| 18-May-22 7:28 PM View: | Bookman Michael General Counsel and Secretary | Immuneering Corp (IMRX) | 17-May-22 | Private Purchase | 1,000 | $4.88 | $4,880.00 | 71% 1.4K to 2.4K | |
| 17-May-22 5:15 PM View: | Keating Laurie Director | Immuneering Corp (IMRX) | 16-May-22 | Private Purchase | 7,000 | $5.00 | $35,000.00 | 100% 7.0K to 14.0K | |
| 12-May-22 5:37 PM View: | Amin Biren CFO, Treasurer | Immuneering Corp (IMRX) | 12-May-22 | Private Purchase | 1,000 | $4.42 | $4,420.00 | 14% 6.9K to 7.9K | |
| 14-Apr-22 4:30 PM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 12-Apr-22 | Option Exercise | 2,000 | $3.01 | $6,020.00 | < 1% 3.15M to 3.15M | |
| 24-Mar-22 4:39 PM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 23-Mar-22 | Private Purchase | 3,000 | $8.02 | $24,060.00 | < 1% 3.15M to 3.15M | |
| 23-Mar-22 6:38 PM View: | Hall Brett Matthew Chief Scientific Officer | Immuneering Corp (IMRX) | 23-Mar-22 | Private Purchase | 1,050 | $7.91 | $8,305.50 | < 1% 329.08K to 330.13K | |
| 22-Mar-22 6:49 PM View: | Barrett Scott Chief Medical Officer | Immuneering Corp (IMRX) | 22-Mar-22 | Private Purchase | 900 | $7.49 | $6,736.50 | 14% 6.66K to 7.56K | |
| 16-Mar-22 5:30 PM View: | Feinberg Peter Director | Immuneering Corp (IMRX) | 15-Mar-22 | Private Purchase | 6,667 | $6.75 | $45,002.20 | < 1% 989.4K to 996.06K | |
| 15-Mar-22 5:53 PM View: | Berman Ann E Director | Immuneering Corp (IMRX) | 15-Mar-22 | Private Purchase | 6,000 | $6.40 | $38,400.00 | 171% 3.5K to 9.5K | |
| 01-Mar-22 5:19 PM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 28-Feb-22 | Option Exercise | 2,000 | $3.01 | $6,020.00 | < 1% 3.15M to 3.15M | |
| 22-Dec-21 5:30 PM View: | Hall Brett Matthew Chief Scientific Officer | Immuneering Corp (IMRX) | 22-Dec-21 | Grant | 322,691 | -- | -- | 5048% 6.39K to 329.08K | |
| 10-Feb-22 10:00 PM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 22-Oct-21 | Gift | 350,000 | -- | -- | 11% 3.15M to 3.5M | |
| 10-Feb-22 10:00 PM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 22-Oct-21 | Gift | 350,000 | -- | -- | (10%) 3.5M to 3.15M | |
| 21-Sep-21 10:00 PM View: | Feinberg Peter Director | Immuneering Corp (IMRX) | 20-Sep-21 | Market Purchase | 4,750 | $24.44 | $116,114.00 | < 1% 984.65K to 989.4K | (6%) |
| 14-Sep-21 4:47 PM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 13-Sep-21 | Market Purchase | 2,083 | $22.87 | $47,632.00 | < 1% 3.15M to 3.15M | < 1% |
| 15-Sep-21 5:58 PM View: | Feinberg Peter Director | Immuneering Corp (IMRX) | 13-Sep-21 | Market Purchase | 5,750 | $21.51 | $123,697.00 | < 1% 978.55K to 984.3K | 7% |
| 15-Sep-21 5:58 PM View: | Feinberg Peter Director | Immuneering Corp (IMRX) | 13-Sep-21 | Market Purchase | 349 | $21.25 | $7,416.25 | < 1% 984.3K to 984.65K | 8% |
| 04-Aug-21 6:05 AM View: | Carpenter Robert J Director | Immuneering Corp (IMRX) | 03-Aug-21 | Conversion | 217,173 | -- | -- | 36% 606.67K to 823.84K | |
| 04-Aug-21 6:04 AM View: | Barrett Scott Chief Medical Officer | Immuneering Corp (IMRX) | 03-Aug-21 | Conversion | 5,996 | -- | -- | 100% 0 to 6.0K | |
| 05-Aug-21 10:00 PM View: | Cormorant Asset Management,... | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 550,000 | $15.00 | $8,250,000.00 | 16% 3.41M to 3.96M | |
| 04-Aug-21 6:06 AM View: | Zeskind Benjamin J. President and CEO Director 10% Owner | Immuneering Corp (IMRX) | 03-Aug-21 | Conversion | 49,099 | -- | -- | 2% 3.09M to 3.14M | |
| 04-Aug-21 6:04 AM View: | Berman Ann E Director | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 3,500 | $15.00 | $52,500.00 | 100% 0 to 3.5K | |
| 04-Aug-21 6:05 AM View: | Hall Brett Matthew Chief Scientific Officer | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 1,353 | $15.00 | $20,295.00 | 27% 5.04K to 6.39K | |
| 04-Aug-21 6:04 AM View: | Amin Biren CFO, Treasurer | Immuneering Corp (IMRX) | 03-Aug-21 | Conversion | 2,723 | -- | -- | 100% 0 to 2.72K | |
| 04-Aug-21 6:06 AM View: | Keating Laurie Director | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 7,000 | $15.00 | $105,000.00 | 100% 0 to 7.0K | |
| 04-Aug-21 6:05 AM View: | Carpenter Robert J Director | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 325,000 | $15.00 | $4,875,000.00 | 39% 823.84K to 1.15M | |
| 04-Aug-21 6:04 AM View: | Barrett Scott Chief Medical Officer | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 667 | $15.00 | $10,005.00 | 11% 6.0K to 6.66K | |
| 04-Aug-21 6:06 AM View: | Feinberg Peter Director | Immuneering Corp (IMRX) | 03-Aug-21 | Conversion | 338,835 | -- | -- | 97% 348.0K to 686.83K | |
| 04-Aug-21 6:05 AM View: | Bookman Michael General Counsel and Secretary | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 1,402 | $15.00 | $21,030.00 | 100% 0 to 1.4K |
